Skip to content

Charles River Laboratories CRL Investment Purchases

Investment Purchases at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$6.7M-95.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$226.1M+47.4%
Danaher logo
DanaherDHR
$20M+11.1%
Arrowhead Research logo
Arrowhead ResearchARWR
$924.64M+43.5%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$14M-94.7%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$13M-35.0%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's investment purchases?
Charles River Laboratories (CRL) reported investment purchases of $8.49M in Q1 2026.
How has Charles River Laboratories's investment purchases changed year-over-year?
Charles River Laboratories's investment purchases increased by 60.2% year-over-year, from $5.3M to $8.49M.
What is the long-term trend for Charles River Laboratories's investment purchases?
Over 4 years (2021 to 2025), Charles River Laboratories's investment purchases has grown at a -18.5% compound annual growth rate (CAGR), from $45.56M to $20.08M.
What does investment purchases mean?
Cash spent on acquiring financial investments or marketable securities.
How do you interpret investment purchases?
Reflects capital allocation strategy; high levels suggest excess cash deployment, while low levels may indicate a focus on core operations.
How does investment purchases compare across companies?
Varies based on corporate treasury policy and M&A strategy.